Target intelligence / Profile preview

Haemophilus influenzae type b (Hib)

Target
Hib
Molecular classification
Other (Bacterium), Gram-negative coccobacillus
01

Overview

Haemophilus influenzae type b (Hib) is a bacterium that causes severe infections, particularly in young children. It is known for causing diseases such as meningitis, pneumonia, and epiglottitis. The Hib vaccine protects against these diseases by inducing immunity against the bacterial capsule, composed of polyribosyl ribitol phosphate (PRP). Hib does not survive outside the human body and is transmitted through respiratory droplets. Its virulence is primarily due to its polysaccharide capsule. The Hib vaccine is part of routine childhood immunization schedules worldwide. It is a gram-negative coccobacillus requiring specific growth factors (hemin and NAD) in vitro.

Other names
Haemophilus influenzae type BHib diseaseHaemophilus influenzae serotype b
02

Mechanism of action

Vaccines induce immunity by stimulating the production of antibodies against the capsular polysaccharide of Hib. Antibiotics target bacterial cell wall synthesis or protein synthesis.

03

Biological functions

ColonizationAdhesion to host cells via piliCapsule production for virulence
04

Disease associations

InfectionMeningitisPneumoniaEpiglottitis
05

Safety considerations

Risks associated with unvaccinated individuals, especially in vulnerable populations like young children and the elderly.Vaccination side effects are generally mild.
06

Interacting drugs

Vaccines (e.g., Hib conjugate vaccines)

1 more in the full profile.

07

Biomarkers

Capsular polysaccharide antibodies (e.g., anti-PRP antibodies)

Beyond the preview

Go deeper on Haemophilus influenzae type b (Hib).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haemophilus influenzae type b (Hib).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call